XML 76 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS AND FINANCIAL INSTRUMENTS (Tables)
12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, by Balance Sheet Grouping The following tables set forth the Company’s assets and liabilities measured at fair value on a recurring (at least annually) and nonrecurring basis by level within the fair value hierarchy (in thousands).
  
Fair value at December 31, 2023
  
Level 1 (1)
Level 2 (2) 
Level 3
Total 
Assets: 
Cash and cash equivalents
$492,393 $— $— $492,393 
Restricted cash
101 — — 101 
Marketable securities
28,351 — — 28,351 
Trade receivables from provisional sales, net
— 86,897 — 86,897 
Deferred consideration
 — — 21,213 21,213 
 $520,845 $86,897 $21,213 $628,955 
Liabilities:
Contingent consideration 
$— $— $29,648 $29,648 
  Option liability - EMX shares (3)
— 1,431 — 1,431 
$— $1,431 $29,648 $31,079 
  
Fair value at December 31, 2022
  
Level 1 (1)
Level 2 (2) 
Level 3
Total 
Assets: 
Cash and cash equivalents
$655,453 $— $— $655,453 
Restricted cash 33,653 — — 33,653 
Marketable securities
44,841 — — 44,841 
Trade receivables from provisional sales, net
— 49,897 — 49,897 
Deferred consideration
 — — 24,369 24,369 
$733,947 $49,897 $24,369 $808,213 
1)Marketable securities of publicly quoted companies, consisting of investments, are valued using a market approach based upon unadjusted quoted prices in an active market obtained from securities exchanges.
2)The Company’s provisional metal sales contracts, included in Trade and other receivables in the Consolidated Balance Sheets, are valued using inputs derived from observable market data, including quoted commodity forward prices. The inputs do not involve significant management judgment. Such instruments are classified within Level 2 of the fair value hierarchy.
3)The fair value of the option liability, which represents the option of the holder to acquire a EMX common share from SSR (refer to Note 3 for further information), was determined using the Black-Scholes model. The inputs to the Black-Scholes model included the EMX share price on the closing date of CAD $2.19 per share, exercise price of CAD $2.27 per Unit, one year maturity, one-year risk-free rate of 4.8%, and annualized volatility of 34.1%.
Schedule of Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation The following table reconciles the beginning and ending balances for financial instruments that are recognized at fair value using significant unobservable inputs (Level 3) in the consolidated financial statements (in thousands):
  20232022
Deferred consideration assets:
Balance as of January 1$24,369 
$
22,610 
Receipt of deferred consideration
(473)— 
Revaluations (2,683) 1,759 
Balance as of December 31
$
21,213 
$
24,369 
  
2023
2022
Contingent consideration liabilities:
Balance as of January 1
$— 
$
— 
Assumption of contingent consideration
 28,600  — 
Revaluations
1,048 — 
Balance as of December 31
$
29,648 
$
— 
Schedule of Fair Value Disclosure of Asset and Liability Not Measured at Fair Value
The fair value of the 2019 Notes and Term Loan as compared to the carrying amounts were as follows: 
December 31,
20232022
Level 
Carrying amount 
Fair value
Carrying amount 
 
Fair value 
2019 Notes (1) 
1
$
227,516 
$
216,545 
$
226,510 
$
257,025 
Term Loan (2) 
2
— — 70,000 71,419 
Total borrowings  
$
227,516 
$
216,545 
$
296,510 
$
328,444 
(1)The fair value disclosed for the Company's 2019 Notes is included in Level 1 as the basis of valuation uses a quoted price in an active market.
(2)The fair value disclosed for the Company's Term Loan is included in Level 2 as the fair value is determined by an independent third-party pricing source. On September 22, 2023, the Term Loan was terminated upon full repayment.